Citizens (NYSE:CIA) reported quarterly losses of $(0.07) per share. This is unchanged from the same period last year.
Gilead’s Kite Reports Collaboration Deal With Appia Bio To Research, Develop Allogeneic Cell Therapies For Cancer
Kite, a Gilead Company (NASDAQ:GILD), and Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced a